首页> 外文期刊>Hospital pharmacy. >Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam
【24h】

Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam

机译:万古霉素和哌拉西林-他唑巴坦的模拟Y位置相容性

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate the physical compatibility of vancomycin with piperacillin-tazobactam during simulated Y-site administration.Methods: Vancomycin and piperacillin-tazobactam were tested using 2 different diluents: 0.9% sodium chloride and 5% dextrose for injection. Vancomycin concentrations of 2, 5, and 10 mg/mL were tested using 0.9% sodium chloride and 4 and 8 mg/mL in 5% dextrose. Piperacillin-tazobactam was diluted to 16, 30, 40, 80, and 100 mg/mL, representing common concentrations used clinically in hospitals, and concentrations were tested in both 0.9% sodium chloride and 5% dextrose for injection. Medications were reconstituted under USP <797> aseptic technique. Combinations were tested in duplicate and reverse order with control solutions. Compatibility testing for Y-site included visual inspection, inspection with a high-intensity monodirectional light source (Tyndall beam), turbidimeter for turbidity evaluation, pH, and microscopic viewing. Testing occurred immediately after mixing, 15 minutes, 60 minutes, and 4 hours. If inconsistencies were observed between samples, testing was repeated to confirm results. Solutions were deemed incompatible if any one test failed and compatible if all tests were accepted.Results: When dextrose 5% for injection was used as the diluent, vancomycin 4 mg/mL was Y-site compatible with piperacillin-tazobactam 16, 30, and 40 mg/mL and incompatible with 80 and 100 mg/mL. Vancomycin 8 mg/mL was incompatible with all tested concentrations of piperacillin-tazobactam. When 0.9% sodium chloride was used as the diluents, Y-site compatibility was found with vancomycin 2 and 5 mg/mL and all tested concentrations of piperacillin-tazobactam. Vancomycin 10 mg/mL was incompatible with piperacillin-tazobactam 40, 80, and 100 mg/mL. Incompatibilities formed a white precipitate immediately on mixing.Conclusion: Y-site incompatibility was greater for the tested concentrations of piperacillin-tazobactam and vancomycin when 5% dextrose was used as the diluent versus 0.9% sodium chloride. Y-site incompatibility was seen immediately in the form of a white precipitate on mixing.
机译:目的:评估万古霉素在模拟Y部位给药时与哌拉西林-他唑巴坦的物理相容性。方法:使用两种不同的稀释剂(分别为0.9%氯化钠和5%葡萄糖注射液)测试万古霉素和哌拉西林-他唑巴坦。使用0.9%的氯化钠以及4%和8 mg / mL的5%葡萄糖测试万古霉素的浓度为2、5和10 mg / mL。将哌拉西林-他唑巴坦稀释至16、30、40、80和100 mg / mL,代表临床上临床上常用的浓度,并在0.9%氯化钠和5%葡萄糖注射液中进行测试。在USP <797>无菌技术下重新配制药物。用对照溶液以重复和相反的顺序测试组合。 Y现场的兼容性测试包括外观检查,高强度单向光源(Tyndall光束)检查,用于浊度评估的浊度计,pH值和显微镜观察。混合15分钟,60分钟和4小时后立即进行测试。如果在样品之间观察到不一致,则重复测试以确认结果。如果任何一项测试失败,则认为溶液不相容;如果所有测试都被接受,则溶液是相容的。结果:当使用注射用5%葡萄糖作为稀释剂时,万古霉素4 mg / mL在Y位点与哌拉西林-他唑巴坦16、30和40 mg / mL,与80和100 mg / mL不相容。万古霉素8 mg / mL与所有测试浓度的哌拉西林-他唑巴坦均不相容。当使用0.9%氯化钠作为稀释剂时,发现与万古霉素2和5 mg / mL以及所有测试浓度的哌拉西林-他唑巴坦均具有Y位相容性。万古霉素10 mg / mL与哌拉西林-他唑巴坦40、80和100 mg / mL不相容。不相容性在混合后立即形成白色沉淀。结论:当使用5%葡萄糖作为稀释剂(相对于0.9%氯化钠)时,对于哌拉西林-他唑巴坦和万古霉素的测试浓度,Y位不相容性更大。混合后立即以白色沉淀的形式看到Y位不相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号